Herbal formula for chronic subdural hematoma
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests a Chinese herbal formula (HuoXue LiShui) to see if it's safe and effective for chronic subdural hematoma, a condition where old blood collects between the brain and its outer covering. If you have this condition and are not needing urgent surgery, this treatment might help your body reabsorb the blood and avoid further problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old
- You have a chronic subdural hematoma confirmed by a brain scan – either the first one or leftover after a drainage surgery
- You are in fairly good neurological condition (you can talk and move normally, and you're fairly independent)
- You have no signs of dangerous brain swelling or urgent need for surgery
- You have not been treated for this condition with other medicines before
- You are not taking blood thinners, steroids, statins, or certain blood pressure medicines at the start of the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two surgical techniques—using a small endoscope (camera) versus a single burr hole—to drain blood from a chronic subdural hematoma (a slow bleed on the brain surface). The goal is to see which method leads to better recovery and fewer complications.
This trial compares two places on the skull to drain a chronic subdural hematoma (a slow collection of blood pressing on the brain). The goal is to see which approach is safer or more effective, which could help improve recovery.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial tests whether a medicine called tranexamic acid (which helps blood clot) can help your body reabsorb a subdural hematoma, a type of bleeding on the brain, without needing surgery. If successful, this treatment could reduce the need for surgery and improve recovery.
This trial tests a minimally invasive procedure to treat chronic subdural hematoma (a slow bleed on the brain). It aims to stop the bleeding and reduce the risk of needing surgery.
Hear when a new Chronic Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.